Rhea-AI Impact
Rhea-AI Sentiment
Rhea-AI Summary
BlackRock announced the expiration and preliminary results of tender offers for three closed-end funds: BSTZ, BCX, and BOE. Each fund offered to repurchase up to 2.5% of its outstanding common shares. The tender offers were significantly oversubscribed, with BCX receiving 20,587,371 shares tendered against 2,056,355 shares offered for repurchase. Due to oversubscription, share purchases will be prorated. The purchase price will be 98% of each fund’s NAV as of November 20, 2024.
BlackRock ha annunciato la scadenza e i risultati preliminari delle offerte pubbliche di acquisto per tre fondi chiusi: BSTZ, BCX e BOE. Ogni fondo ha offerto di riacquistare fino al 2,5% delle sue azioni ordinarie in circolazione. Le offerte pubbliche di acquisto sono state significativamente sovrascritte, con BCX che ha ricevuto 20.587.371 azioni offerte rispetto a 2.056.355 azioni disponibili per il riacquisto. A causa della sovrascrizione, gli acquisti di azioni saranno ripartiti proporzionalmente. Il prezzo di acquisto sarà il 98% del NAV di ciascun fondo al 20 novembre 2024.
BlackRock anunció la fecha de vencimiento y los resultados preliminares de las ofertas públicas de compra para tres fondos cerrados: BSTZ, BCX y BOE. Cada fondo ofreció recomprar hasta el 2.5% de sus acciones comunes en circulación. Las ofertas fueron considerablemente sobre suscritas, con BCX recibiendo 20,587,371 acciones presentadas en comparación con 2,056,355 acciones ofrecidas para la recompra. Debido a la sobresuscripción, las compras de acciones serán prorrateadas. El precio de compra será el 98% del NAV de cada fondo a partir del 20 de noviembre de 2024.
블랙록은 세 개의 폐쇄형 펀드 BSTZ, BCX, BOE에 대한 입찰 기간 만료 및 초기 결과를 발표했습니다. 각 펀드는 발행된 보통주식의 최대 2.5%를 재매입할 것을 제안했습니다. 입찰은 크게 초과 신청되었으며, BCX는 20,587,371주가 제안되었고, 2,056,355주의 재매입이 제안되었습니다. 초과 신청으로 인해 주식 구매는 비례 배분될 것입니다. 구매 가격은 2024년 11월 20일 기준 각 펀드의 NAV의 98%가 될 것입니다.
BlackRock a annoncé l’expiration et les résultats préliminaires des offres publiques d’achat pour trois fonds fermés : BSTZ, BCX et BOE. Chaque fonds a proposé de racheter jusqu’à 2,5 % de ses actions ordinaires en circulation. Les offres ont été considérablement sursouscrites, avec BCX recevant 20 587 371 actions soumises contre 2 056 355 actions proposées pour rachat. En raison de la sursouscription, les achats d’actions seront proratisés. Le prix d’achat sera de 98 % de la valeur nette d’inventaire (VNI) de chaque fonds au 20 novembre 2024.
BlackRock gab die Frist und die vorläufigen Ergebnisse der öffentlichen Kaufangebote für drei Geschlossene Fonds bekannt: BSTZ, BCX und BOE. Jeder Fonds bot an, bis zu 2,5% seiner ausgegebenen Stammaktien zurückzukaufen. Die Kaufangebote waren erheblich überzeichnet, wobei BCX 20.587.371 angebotene Aktien erhielt, während 2.056.355 Aktien zum Rückkauf angeboten wurden. Aufgrund der Überzeichnung werden die Aktienkäufe anteilig verteilt. Der Kaufpreis beträgt 98% des NAV jedes Fonds zum 20. November 2024.
Positive
- Purchase price set at 98% of NAV indicates strong shareholder value proposition
- High subscription rate demonstrates strong market interest in the tender offer
Negative
- Significant oversubscription means most shareholders won’t be able to tender their desired amount of shares
- Purchase price at 2% discount to NAV represents a small loss for participating shareholders
Insights
The tender offer results reveal significant shareholder interest in liquidating positions, with all three BlackRock funds experiencing substantial oversubscription. For BCX specifically, the 20,587,371 shares tendered vastly exceeded the 2,056,355 shares offered for repurchase, indicating strong selling pressure at a 2% discount to NAV. This overwhelming response suggests shareholders are eager to exit their positions, potentially due to broader market concerns about commodities and resources sectors.
The heavy oversubscription means shareholders will face significant proration, likely receiving the ability to sell only about 10% of their tendered shares. The 98% of NAV purchase price represents a modest premium to typical market prices, though the acceptance rate diminishes the practical benefit for most shareholders. This development may create temporary selling pressure as disappointed shareholders seek alternative exit routes.
NEW YORK–(BUSINESS WIRE)– The BlackRock closed-end funds (the “Funds”) listed below announced today the expiration and preliminary results of each Fund’s tender offer (each, a “Tender Offer”) for up to 2.5% of its outstanding common shares (the “Shares”).
Each Tender Offer commenced on October 17, 2024 and expired at 5:00 p.m. Eastern time on November 19, 2024.
Based on preliminary information, the number of Shares properly tendered for each Fund and not withdrawn is noted in the table below.
|
Fund Name |
Ticker |
CUSIP |
Shares Offered |
Shares Tendered |
|
BlackRock Science and |
BSTZ |
09260K101 |
1,854,222 |
19,714,994 |
|
BlackRock Resources & |
BCX |
09257A108 |
2,056,355 |
20,587,371 |
|
BlackRock Enhanced Global |
BOE |
092501105 |
1,499,691 |
14,941,364 |
Based on the preliminary results shown above, because the Tender Offer was oversubscribed for each Fund, the relative number of Shares that will be purchased from each shareholder is expected to be prorated based on the number of Shares properly tendered for the Fund. The purchase price of properly tendered and accepted Shares for each Fund will be 98% of the Fund’s net asset value (“NAV”) as of the close of regular trading on the New York Stock Exchange on November 20, 2024, the business day immediately following the expiration date of the Tender Offer. The above-indicated results are based on preliminary information, are subject to adjustment and should not be regarded as final. Each Fund expects to announce the final results of its Tender Offer, including the pro-ration factor, if applicable, on or about November 20, 2024.
Questions regarding the Tender Offers may be directed to Georgeson LLC, the Information Agent for the Tender Offers, toll free at the numbers disclosed in each Fund’s Offer to Purchase.
Important Notice
This press release is for informational purposes only and shall not constitute a recommendation, an offer to purchase or a solicitation of an offer to sell any common shares of the Funds. The offer to purchase a Fund’s common shares was made only pursuant to an offer to purchase, a related letter of transmittal and other documents filed with the U.S. Securities and Exchange Commission (“SEC”) as exhibits to a tender offer statement on Schedule TO. Shareholders may obtain a free copy of the offer to purchase and other documents filed with the SEC at the website maintained by the SEC at www.sec.gov or by directing such requests to the applicable Fund.
About BlackRock
BlackRock’s purpose is to help more and more people experience financial well-being. As a fiduciary to investors and a leading provider of financial technology, we help millions of people build savings that serve them throughout their lives by making investing easier and more affordable. For additional information on BlackRock, please visit www.blackrock.com/corporate.
Availability of Fund Updates
BlackRock will update performance and certain other data for the Funds on a monthly basis on its website in the “Closed-end Funds” section of www.blackrock.com as well as certain other material information as necessary from time to time. Investors and others are advised to check the website for updated performance information and the release of other material information about the Funds. This reference to BlackRock’s website is intended to allow investors public access to information regarding the Funds and does not, and is not intended to, incorporate BlackRock’s website in this release.
Forward-Looking Statements
This press release, and other statements that BlackRock or a Fund may make, may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act, with respect to a Fund’s or BlackRock’s future financial or business performance, strategies or expectations. Forward-looking statements are typically identified by words or phrases such as “trend,” “potential,” “opportunity,” “pipeline,” “believe,” “comfortable,” “expect,” “anticipate,” “current,” “intention,” “estimate,” “position,” “assume,” “outlook,” “continue,” “remain,” “maintain,” “sustain,” “seek,” “achieve,” and similar expressions, or future or conditional verbs such as “will,” “would,” “should,” “could,” “may” or similar expressions.
BlackRock cautions that forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Forward-looking statements speak only as of the date they are made, and BlackRock assumes no duty to and does not undertake to update forward-looking statements. Actual results could differ materially from those anticipated in forward-looking statements and future results could differ materially from historical performance.
With respect to the Funds, the following factors, among others, could cause actual events to differ materially from forward-looking statements or historical performance: (1) changes and volatility in political, economic or industry conditions, the interest rate environment, foreign exchange rates or financial and capital markets, which could result in changes in demand for the Funds or in a Fund’s net asset value; (2) the relative and absolute investment performance of a Fund and its investments; (3) the impact of increased competition; (4) the unfavorable resolution of any legal proceedings; (5) the extent and timing of any distributions or share repurchases; (6) the impact, extent and timing of technological changes; (7) the impact of legislative and regulatory actions and reforms, and regulatory, supervisory or enforcement actions of government agencies relating to a Fund or BlackRock, as applicable; (8) terrorist activities, international hostilities, health epidemics and/or pandemics and natural disasters, which may adversely affect the general economy, domestic and local financial and capital markets, specific industries or BlackRock; (9) BlackRock’s ability to attract and retain highly talented professionals; (10) the impact of BlackRock electing to provide support to its products from time to time; and (11) the impact of problems at other financial institutions or the failure or negative performance of products at other financial institutions.
Annual and Semi-Annual Reports and other regulatory filings of the Funds with the Securities and Exchange Commission (“SEC”) are accessible on the SEC’s website at www.sec.gov and on BlackRock’s website at www.blackrock.com, and may discuss these or other factors that affect the Funds. The information contained on BlackRock’s website is not a part of this press release.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241119088004/en/
1-800-882-0052
Source: BlackRock Closed-End Funds
FAQ
How many shares were tendered in BlackRock Resources & Commodities Strategy Trust (BCX) tender offer?
BCX received 20,587,371 shares tendered in the tender offer, significantly exceeding the 2,056,355 shares offered for repurchase.
What is the purchase price for shares in the BlackRock funds tender offer?
The purchase price will be 98% of each fund’s net asset value (NAV) as of November 20, 2024.
Why will shares be prorated in the BlackRock BCX tender offer?
Shares will be prorated because the tender offer was significantly oversubscribed, with tendered shares far exceeding the 2.5% of outstanding shares offered for repurchase.
